1 INTRODUCTION
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF HYPERTENSION DRUG MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL HYPERTENSION DRUG MARKET SNAPSHOT
3.2 GLOBAL HYPERTENSION DRUG MARKET REVENUE, 2017– 2025(US$ MN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL HYPERTENSION DRUG MARKET, BY TYPE
5.1 OVERVIEW
5.2 BETA BLOCKERS
5.3 DIURETICS
5.4 RENIN INHIBITORS
5.5 ALPHA-BETA BLOCKERS
5.6 ALPHA BLOCKERS
5.7 VASODILATORS
5.8 CALCIUM CHANNEL BLOCKERS
5.9 OTHERS
6 GLOBAL HYPERTENSION DRUG MARKET, BY GEOGRAPHY
6.1 NORTH AMERICA
6.1.1 MARKET DYNAMICS
6.1.1.1 DRIVERS
6.1.1.2 RESTRAINS
6.1.1.3 OPPORTUNITY
6.1.2 U.S.
6.1.3 CANADA
6.1.4 MEXICO
6.2 EUROPE
6.2.1 MARKET DYNAMICS
6.2.1.1 DRIVERS
6.2.1.2 RESTRAINS
6.2.1.3 OPPORTUNITY
6.2.2 U.K.
6.2.3 FRANCE
6.2.4 GERMANY
6.2.5 REST OF EUROPE
6.3 ASIA PACIFIC
6.3.1 MARKET DYNAMICS
6.3.1.1 DRIVERS
6.3.1.2 RESTRAINS
6.3.1.3 OPPORTUNITY
6.3.2 INDIA
6.3.3 CHINA
6.3.4 JAPAN
6.3.5 REST OF ASIA PACIFIC
6.4 MIDDLE EAST AND AFRICA
6.4.1 MARKET DYNAMICS
6.4.1.1 DRIVERS
6.4.1.2 RESTRAINS
6.4.1.3 OPPORTUNITY
6.4.2 SOUTH AFRICA
6.4.3 REST OF MIDDLE EAST AND AFRICA
6.5 LATIN AMERICA
6.5.1 MARKET DYNAMICS
6.5.1.1 DRIVERS
6.5.1.2 RESTRAINS
6.5.1.3 OPPORTUNITY
6.5.2 BRAZIL
6.5.3 REST OF LATIN AMERICA
7 COMPETATIVE LANDSCAPE
7.1 OVERVIEW
7.2 NEW PRODUCT LAUNCHES
8 GLOBAL HYPERTENSION DRUG MARKET, BY COMPANY
8.1 INTRODUCTION
8.2 NOVARTIS AG
8.2.1 BUSINESS OVERVIEW
8.2.2 PRODUCTS & SERVICES
8.2.3 KEY STRATEGY
8.2.4 RECENT DEVELOPMENTS
8.2.5 SWOT ANALYSIS
8.3 ACTELION LTD.
8.3.1 BUSINESS OVERVIEW
8.3.2 PRODUCTS & SERVICES
8.3.3 KEY STRATEGY
8.3.4 RECENT DEVELOPMENTS
8.3.5 SWOT ANALYSIS
8.4 SANOFI SA
8.4.1 BUSINESS OVERVIEW
8.4.2 PRODUCTS & SERVICES
8.4.3 KEY STRATEGY
8.4.4 RECENT DEVELOPMENTS
8.4.5 SWOT ANALYSIS
8.5 JOHNSON & JOHNSON LTD.
8.5.1 BUSINESS OVERVIEW
8.5.2 PRODUCTS & SERVICES
8.5.3 KEY STRATEGY
8.5.4 RECENT DEVELOPMENTS
8.5.5 SWOT ANALYSIS
8.6 PFIZER INC.
8.6.1 BUSINESS OVERVIEW
8.6.2 PRODUCTS & SERVICES
8.6.3 KEY STRATEGY
8.6.4 RECENT DEVELOPMENTS
8.6.5 SWOT ANALYSIS
8.7 LUPIN LIMITED
8.7.1 BUSINESS OVERVIEW
8.7.2 PRODUCTS & SERVICES
8.7.3 KEY STRATEGY
8.7.4 RECENT DEVELOPMENTS
8.7.5 SWOT ANALYSIS
8.8 GLAXOSMITHKLINE PLC
8.8.1 BUSINESS OVERVIEW
8.8.2 PRODUCTS & SERVICES
8.8.3 KEY STRATEGY
8.8.4 RECENT DEVELOPMENTS
8.8.5 SWOT ANALYSIS
8.9 MERCK & CO.
8.9.1 BUSINESS OVERVIEW
8.9.2 PRODUCTS & SERVICES
8.9.3 KEY STRATEGY
8.9.4 RECENT DEVELOPMENTS
8.9.5 SWOT ANALYSIS